Alfa Wassermann Separation Technologies is a division of Alfa Wassermann Inc. (AWI) and is the leading provider of ultracentrifugation solutions for process development and industrial scale manufacturing. Their continuous flow ultracentrifuges are designed, manufactured, and serviced for efficient and reliable use in the separation, fractionation, and concentration of various substances including viral vectors, virus-like particles, viruses, viral and bacterial vaccines, macromolecules, and cellular organelles. These solutions are crucial for the development and production of vaccines and bio-products, meeting cGMP requirements from protocol development to pilot scale to industrial scale production. Their systems include a range of rotors allowing batch and continuous flow operations with process volumes of up to two hundred liters, and scalable rotors that enable protocol development to be scaled-up while retaining similar recovery and critical process parameters. With the recent addition of AWST Automated Fluid Handling (AFH), customers can now benefit from a fully automated and standardized biomanufacturing process. This technology enhances the efficiency and reliability of critical processes, setting a new standard in the industry. Overall, Alfa Wassermann Separation Technologies is a promising player in the IT and Industrial sectors with a strong focus on innovation and meeting the evolving needs of the biopharmaceutical industry.
There is no investment information
No recent news or press coverage available for Alfa Wassermann Separation Technologies.